Trial Details
Not RecruitingBasic Information
| Clinical ID | c5503 |
|---|---|
| Identifier | ACTRN12612001067864 |
| Trial Title | A randomised controlled pilot trial to evaluate the efficacy of fluoxetine in maintaining remission in Crohn's disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | inflammatory bowel disease; inflammatory bowel disease;Oral and Gastrointestinal - Inflammatory bowel disease |
| Interventions | Fluoxetine was selected based on previous research showing its anti-inflammatory properties in humans, and in relation to IBD based on findings of studies examining animal models of colitis. Previous human studies have recommended a dose of 20mg daily (wh |
Participant Information
| Sponsor | University of South Australia |
|---|---|
| City | NULL |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |